IDE and Alzheimer disease: The age-/pathology-related decrease of the concentration and/or activity of Aβ-degrading enzymes (i.e., neprilysin (NEP) and insulin-degrading enzyme (IDE)) could be the triggers of the onset and progression of AD [17].